What Cencora's 8-K filings say: 11 filings, latest Sep 25, 2026
Cencora filed its latest 8-K with the SEC on Sep 25, 2026. It discusses board change, governance change and restructuring.
Public (COR)Pharmaceutical Manufacturing10,000+ employeescencora.comLinkedIn
- Filed
- Sep 25, 2026
- Filings
- 11
- Signals
- 28
8-K · latest 10
What Cencora's 8-K filings say
- SEC EDGAR
8-K
Filed · 3 signals
The appointment of a new director and expansion of the board signals a potential shift in governance and strategy.
- SEC EDGAR
8-K
Filed · 1 signal
Board member Dr. Lorence H. Kim resigns from Cencora effective August 13, 2026
The immediate resignation of Dr. Lorence H.
- SEC EDGAR
8-K
Filed · 2 signals
Cencora loses a portion of business volume from key customer Walgreens
Cencora confirmed that as of July 1, 2026, some business volume from its major customer, Walgreens, has moved to another provider.
Cencora reports loss of some Walgreens service volume starting July 2026
A portion of Cencora's business with major customer Walgreens is moving to an external provider, creating a potential revenue gap and competitive pressure.
- SEC EDGAR
8-K
Filed · 3 signals
Cencora increases credit facility by $1.5B to $7.0B, securing capital for strategic initiatives.
Cencora has significantly increased its borrowing capacity by amending its multi-currency revolving credit facility to $7.0 billion and extending the maturity to 2031.
$7B
New total size of the amended multi-currency senior unsecured revolving credit facility after a $1.5 billion increase.
JPMorgan Chase Bank, N.A.MUFG Bank, Ltd.
- SEC EDGAR
8-K
Filed · 3 signals
- SEC EDGAR
8-K
Filed · 3 signals
New C-suite executives often re-evaluate financial systems, reporting tools, and operational processes within their first 90-180 days to establish their strategy and identify efficiency gains.
$1M
New CFO Eva Boratto's annual base salary.
- SEC EDGAR
8-K
Filed · 4 signals
This acquisition represents a significant strategic investment and will necessitate major post-merger integration activities.
Cencora to acquire EyeSouth Partners’ retina business, triggering post-merger integration.
This acquisition will necessitate the integration of business units, systems, and processes between Cencora and EyeSouth Partners.
Earlier 8-K filings
Showing 10 of 28 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Cencora with the Signal API
One POST /v1/companies/enrich call with cencora.com returns Cencora 8-K signals (sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"cencora.com","signal_types":["sec-8k"],"limit":20}'Same industry
8-K at related companies
Questions about Cencora 8-K
When did Cencora file its latest 8-K?
What did Cencora disclose in its latest 8-K?
Where can I read Cencora's 8-K filing?
Source. Current reports (Form 8-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .